Survey Reveals Variability in Ketamine-Assisted Psychotherapy

Introduction to Ketamine-Assisted Psychotherapy

Ketamine-assisted psychotherapy (KAP) is gaining traction as a treatment for depression, leveraging ketamine's potential to enhance neuroplasticity and facilitate transformative psychological experiences. A recent survey published on June 10, 2026, in OpenAlex highlights the variability in KAP practices among providers, pointing to the need for standardized protocols.

Current Practices and Modalities

The survey involved fifty licensed KAP providers from a U.S.-based online network, including physicians, clinical psychologists, and social workers. Ketamine was most often administered intramuscularly (42%) or sublingually (40%), frequently at psychedelic-dose ranges. Psychotherapy was typically conducted before, during, and after ketamine administration, with Internal Family Systems, humanistic/existential, and supportive modalities being the most common approaches.

Practitioners often adopted an eclectic approach, blending three to four different psychotherapy modalities on average. The primary treatment goals included fostering inner healing intelligence, leveraging neuroplastic effects, and facilitating transformative experiences. However, there was no significant correlation between the chosen psychotherapy modalities and the treatment goals, indicating a lack of clear rationale for matching therapeutic approaches to desired outcomes.

Implications for Clinical Trials and Protocol Development

The findings from this survey underscore the necessity for comparative clinical trials to establish evidence-based standards for KAP. Such trials could help clarify the most effective combinations of administration routes and psychotherapy modalities, ultimately informing the development of standardized protocols for psychedelic-assisted therapies.

Standardization is crucial not only for enhancing clinical efficacy but also for guiding regulatory frameworks that oversee the use of psychedelic therapies. As the field of psychedelic-assisted psychotherapy continues to evolve, evidence-based standards will be essential for ensuring safe and effective treatments.

Risks and Unknowns in KAP

Despite the promising potential of KAP, several risks and unknowns remain. The variability in practices highlights the need for caution, as inconsistent approaches could lead to unpredictable outcomes. Additionally, the lack of clear associations between psychotherapy modalities and treatment goals suggests that more research is needed to understand how different therapeutic approaches interact with ketamine's effects.

Potential side effects of ketamine, such as dissociation and altered states of consciousness, also warrant careful consideration. Ensuring that practitioners are adequately trained to manage these effects is vital for patient safety.

Looking Forward

As interest in KAP and other psychedelic-assisted therapies continues to grow, the development of evidence-based standards will be critical. Future research should focus on conducting rigorous clinical trials to determine the most effective practices and protocols. These efforts will not only enhance clinical outcomes but also support the integration of psychedelic therapies into mainstream mental health care.

The insights gained from this survey provide a valuable foundation for future research and policy development, paving the way for a more standardized and effective approach to psychedelic-assisted psychotherapy.